BIOANALYTICAL SYSTEMS INC company info

CIK 720154
IRS Number 351345024
State of incorporation IN
Business address 2701 KENT AVE
None
WEST LAFAYETT
IN
47906-1382
Mail address 2701 KENT AVENUE
None
WEST LAFAYETTE
IN
47906-1382

Short summary

BIOANALYTICAL SYSTEMS INC is a Indiana company, with head office located at 2701 Kent Ave West Lafayett, Indiana 47906-1382. In 2018 the company owned a total of 31.27 million USD worth of assets, including 8.06 million USD worth of current assets. 2010 was the year when the company amassed the most assets.

BIOANALYTICAL SYSTEMS INC Income Statement

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Revenue, Net 28.7833.1428.2122.0724.5822.7020.4424.24
Cost of Goods and Services Sold 21.4522.6421.3715.0116.6215.2116.0216.5518.23
Gross Profit 7.3310.516.847.067.967.494.437.708.12
Research and development 0.550.530.540.450.660.720.500.470.60
Operating Expenses 9.339.229.336.237.636.587.476.428.10
Operating Income (Loss) -2.001.29-5.690.830.330.91-3.041.280.01
Interest expense 1.030.710.710.650.490.290.400.380.27
Other Nonoperating Income (Expense) 0.010.010.010.01
Income Tax Expense (Benefit) -0.330.050.000.020.010.02-0.010.02-0.06
Net income -2.692.30-6.390.77-1.071.10-3.230.88-0.19

BIOANALYTICAL SYSTEMS INC Balance Sheet

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Cash and cash equivalents 1.504.630.410.310.740.520.490.921.460.77
Accounts Receivable, Net, Current 3.713.672.782.653.232.502.063.214.13
Inventories 1.651.751.481.541.561.481.060.961.18
Property, Plant and Equipment, Gross 45.7642.4240.5241.1341.6942.8042.8548.44
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 25.3623.8023.6025.1825.7026.6727.8831.83
Goodwill 1.381.381.381.381.011.010.040.043.07
Intangible Assets, Net (Excluding Goodwill) 0.060.030
Other Assets, Noncurrent 0.060.060.050.040.030.030.020.020.03
Total assets 34.3128.7824.1824.8623.3623.5120.4021.5531.27
Current assets 12.187.245.377.126.676.315.056.588.06
Accounts payable 1.702.523.853.372.453.951.662.093.19
Total current liabilities 10.7615.9714.429.977.9313.817.868.9911.80
Long-term Debt, Excluding Current Maturities 6.015.844.653.8604.214.008.55
Long-term Debt 6.585.845.255.244.453.674.459.61
Total liabilities 18.0516.2415.0211.9314.0412.1712.9820.38
Common Stock, Value, Issued 1.691.781.881.981.991.992.022.152.52
Retained Earnings (Accumulated Deficit) -7.04-11.79-13.97-14.39-12.98-14.89-16.27-16.04-16.23
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.100.060.10-0.070.02-0.0500

BIOANALYTICAL SYSTEMS INC Cash Flow

Name [in Millions USD]2009201020112012201320142015201620172018Trends
Net income -2.692.30-6.390.77-1.071.10-3.230.88-0.19
Depreciation and amortization 2.322.132.281.721.601.411.561.681.88
Depreciation 2.092.221.721.591.401.401.521.69
Amortization of Intangible Assets 0.030.050.17
Deferred Income Tax Expense (Benefit) 0.01-0.01
Accounts receivable -0.650.24-0.92-0.01-0.911.08-1.640.940.59
Inventories -0.17-0.040.02-0.280.19-0.10-0.01-0.540.27
Accounts payable -0.09-0.482.38-0.27-0.860.261.12-0.910.98
Net Cash Provided by (Used in) Operating Activities 2.441.09-0.201.521.061.243.49
Payments to Acquire Productive Assets 1.090.010.491.471.260.351.32
Net Cash Provided by (Used in) Investing Activities -0.45-1.17-0.860.01-1.26-0.34-8.07
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0.01-0.49-1.43-1.26
Proceeds from Issuance of Long-term Debt 5.50004.505.50
Net Cash Provided by (Used in) Financing Activities -1.461.66-1.16-0.950.14-0.854.93
Cash and Cash Equivalents, Period Increase (Decrease) 0.551.54-2.240.58-0.32-0.54-0.050.050.34